Edith Oláh

17.2k citations

138 papers · 13.0k · 4 hit papers · h-index 46

Impact in

Genetics top 0.1%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities
- Genetic Associations and Epidemiology
Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment

Papers in

Genetics 62
- BRCA gene mutations in cancer 48
- Genomic variations and chromosomal abnormalities 14
Cancer Research 23

Co-authors: George F. Weber (18 shared papers)Béla Csókay (6 shared papers)Tamás István Orbán (5 shared papers)J. Papp (16 shared papers)Noémi Prajda (5 shared papers)May S. Lui (6 shared papers)Yutaka Natsumeda (7 shared papers)Diana Y. Tzeng (5 shared papers)
Journals: Breast Cancer Research (6 papers)Nature Genetics (6 papers)JNCI Journal of the National Cancer Institute (5 papers)Pathology & Oncology Research (4 papers)Life Sciences (4 papers)
Partner nations: Hungary United Kingdom United States

In The Last Decade

Edith Oláh

138 papers receiving 12.5k citations

Edith Oláh's Hit Papers

align trajectories log scale

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses 2020 · 303 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2020 Nature Genetics
2017 JAMA
2015 JAMA
2003 The American Journal of Human Genetics

Peers

Countries citing papers authored by Edith Oláh

Since Specialization

Citations

This map shows the geographic impact of Edith Oláh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Oláh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Oláh more than expected).

Fields of papers citing papers by Edith Oláh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Oláh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Oláh. The network helps show where Edith Oláh may publish in the future.

Co-authors

The 25 scholars most cited alongside Edith Oláh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edith Oláh Line = papers co-authored together Edith Oláh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies The American Journal of Human Genetics ·Antonis C. Antoniou, Paul D.P. Pharoah, Steven Alexander Narod, Harvey A. Risch, J.E. Eyfjörd, John Llewelyn Hopper, Niklas Loman, Hakan Lars Olsson Hit paper breakdown →	2003	2866
2	Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers JAMA ·Karoline B. Kuchenbaecker, John Llewelyn Hopper, Daniel R. Barnes, Kelly‐Anne Phillips, Thea M. Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E. van Leeuwen Hit paper breakdown →	2017	2111
3	Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype Clinical Cancer Research ·Sunil R. Lakhani, Jorge Sergio Reis-Filho, Laura G. Fulford, Frederique Madeleine Penault-Llorca, Marc van der Vijver, Suzanne Parry, D. Timothy Bishop, Javier Benı́tez	2005	520
4	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Nature Genetics ·Australian Cancer Study, Stig Bojesen, Australian Ovarian Cancer Study, Gene Environment Interaction and Breast Cancer (GENICA), Swedish Breast Cancer Study (SWE-BRCA), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Karen A. Pooley	2013	463
5	The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions British Journal of Cancer ·Antonis C. Antoniou, Alex Cunningham, Julian Peto, D. Gareth Evans, Fiona Lalloo, Steven Alexander Narod, Harvey A. Risch, Jorunn Erla Eyfjord	2008	403
6	Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer JAMA ·Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue C. Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench Hit paper breakdown →	2015	397
7	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Nature Genetics ·Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel R. Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara Hit paper breakdown →	2020	303
8	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Nature Genetics ·Roger Laughlin Milne, Karoline B. Kuchenbaecker, K Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon	2017	298
9	Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations Human Mutation ·Timothy Richard Rebbeck, Tara M. Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Ki-Wa Tin. Kwong, Edith Oláh, Olufunmilayo Ibironke Olopade	2018	242
10	Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study The Lancet Oncology ·Marlies J. E. Kempers, Roland P. Kuiper, Charlotte W. Ockeloen, Pierre Olivier Chappuis, Pierre Hutter, Nils Rahner, Hans K. Schackert, Verena Steinke	2010	226
11	Identification of six new susceptibility loci for invasive epithelial ovarian cancer Nature Genetics ·Karoline B. Kuchenbaecker, Susan J. Ramus, Jonathan P. Tyrer, Andrew S. Lee, Howard C. Shen, Jonathan Beesley, Kate Lawrenson, Lesley McGuffog	2015	196
12	The Y Deletion gr/gr and Susceptibility to Testicular Germ Cell Tumor The American Journal of Human Genetics ·Katherine Nathanson, Peter Kanetsky, Rachel Hawes, David J. Vaughn, Richard Letrero, Katherine Mary Tucker, Michael Leonard Friedlander, Kelly‐Anne Phillips	2005	175
13	Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) JNCI Journal of the National Cancer Institute ·Nadine Andrieu, David E. Goldgar, Douglas F. Easton, Matti A. Rookus, Richard M. Brohet, Antonis C. Antoniou, Susan Peock, D. Gareth Evans	2006	163
14	Molecular mechanisms in the antiproliferative action of quercetin Life Sciences ·Béla Csókay, Noémi Prajda, George F. Weber, Edith Oláh	1997	153
15	Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. PubMed ·Leendert H. J. Looijenga, Hubert de Leeuw, Monique van Oorschot, Ruud J. H. L. M. van Gurp, Hans Stoop, Ad Gillis, Carlos A. de Gouveia Brazao, Rob F.A. Weber	2003	146
16	Haplotype and Phenotype Analysis of Nine Recurrent BRCA2 Mutations in 111 Families: Results of an International Study The American Journal of Human Genetics ·Susan L. Neuhausen, Andrew K. Godwin, Ruth Gershoni‐Baruch, Elizabeth L. Schubert, Judy Ellen Garber, Dominique Stoppa-Lyonnet, Edith Oláh, Béla Csókay	1998	140
17	Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores Journal of Clinical Oncology ·Julie Lecarpentier, Valentina Silvestri, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie	2017	139
18	Deletions removing the last exon ofTACSTD1constitute a distinct class of mutations predisposing to Lynch syndrome Human Mutation ·Marietta Eva Kovacs, J. Papp, Zoltán Szentirmay, Szabolcs Ottó, Edith Oláh	2009	135
19	Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 Nature Genetics ·Alison Margaret Dunning, K Kyriaki Michailidou, Karoline B. Kuchenbaecker, Deborah J. Thompson, Juliet D. French, Jonathan Beesley, Catherine S. Healey, Siddhartha Kar	2016	124
20	Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes Nature Genetics ·Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen, Siddhartha Kar, Karen A. Pooley, Joe Dennis	2020	120

About Edith Oláh

Edith Oláh is a scholar working on Genetics, Cancer Research, Reproductive Medicine, Molecular Biology and Oncology, having authored 138 papers that have together received 13.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (48 papers), Biochemical and Molecular Research (20 papers), Genetic factors in colorectal cancer (16 papers), Ovarian cancer diagnosis and treatment (15 papers), Genomic variations and chromosomal abnormalities (14 papers), DNA Repair Mechanisms (10 papers), Testicular diseases and treatments (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Genetics (7.0k citations), Reproductive Medicine (1.5k citations), Cancer Research (2.3k citations), Pathology and Forensic Medicine (1.7k citations) and Oncology (2.4k citations). Edith Oláh has collaborated with scholars based in Hungary, United Kingdom and United States. Frequent co-authors include George F. Weber, Béla Csókay, Tamás István Orbán, J. Papp, Noémi Prajda, May S. Lui, Yutaka Natsumeda, Diana Y. Tzeng, Zoltán Szentirmay and Szabolcs Ottó. Their work appears in journals such as Breast Cancer Research, Nature Genetics, JNCI Journal of the National Cancer Institute, Pathology & Oncology Research and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Edith Oláh

Impact in

Papers in i

In The Last Decade

Edith Oláh

Edith Oláh's Hit Papers

Peers

Countries citing papers authored by Edith Oláh

Fields of papers citing papers by Edith Oláh

All Works

About Edith Oláh

Explore authors with similar magnitude of impact

Papers in